A Retrospective Study of Biliary Drainage Strategies for Patients with Malignant Hilar Biliary Strictures

Xin-Yue Liang,1,2 Wen Li,1,2 Fang Liu,1,2 Xin-Dan Kang1,2 1Medical School of Chinese People’s Liberation Army (PLA), Beijing, People’s Republic of China; 2Department of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital, Beijing, People’s Republic of ChinaCorrespondence: Wen LiMedical School of Chinese People’s Liberation Army (PLA), Yard 28, Fuxing Street, Haidian District, Beijing, People’s Republic of ChinaTel +86 13911589119Fax +86 10 55499307Email liwen2000@yahoo.comPurpose: The main aim of this study was to compare the efficacy and safety of different biliary drainage strategies, including percutaneous transhepatic biliary drainage (PTBD) versus endoscopic biliary stenting (EBS) and unilateral versus bilateral stenting, in patients with unresectable malignant hilar biliary strictures (MHBSs).Patients and Methods: This was a retrospective review of patients with inoperable MHBSs who underwent biliary drainage by either EBS or PTBD. Efficacy and safety were compared between the two pathways and between unilateral and bilateral stenting in the EBS group. The survival duration was analyzed with K-M curves and Log rank tests.Results: From January 2015 to December 2019, a total of 206 (126: EBS and 80: PTBD) patients with MHBSs were enrolled in our study and underwent 270 procedures (173: EBS and 97: PTBD). Bilateral stenting was superior to unilateral stenting in terms of clinical success (69.6% vs 50.6%, p=0.039), especially for patients with Bismuth type IV (70.0% vs 30.3%, p=0.002). A higher decrease in bilirubin was seen with PTBD in patients with Bismuth types III–IV (66.9 vs 36.7, p=0.006). A survival advantage was seen in successful drainage (227 days vs 82 days, p< 0.001), lower tumor-node-metastasis (TNM) scores (I–II) (195 days vs 139 days, p=0.012), and cholangiocarcinoma (184 days vs 84 days, p=0.001).Conclusion: For patients with advanced MHBSs, bilateral stenting may achieve a better drainage effect than unilateral stenting, and PTBD may have a better performance in relieving cholestasis than EBS. Successful drainage and cholangiocarcinoma may provide greater long-term survival benefits.Keywords: inoperable hilar malignancy, endoscopic biliary stenting, percutaneous transhepatic biliary drainage, survival